"use strict";(self.webpackChunkBenStockTracker=self.webpackChunkBenStockTracker||[]).push([[5676],{5676:e=>{e.exports=JSON.parse('{"8646f772-72cf-3fff-b727-99874e37aec6":{"uuid":"8646f772-72cf-3fff-b727-99874e37aec6","title":"Gilead Sciences (GILD) Stock Moves -0.21%: What You Should Know","publisher":"Zacks","link":"https://finance.yahoo.com/news/gilead-sciences-gild-stock-moves-214509187.html","providerPublishTime":1658871909,"type":"STORY","thumbnail":{"resolutions":[{"url":"https://s.yimg.com/uu/api/res/1.2/QTwafwrkeqiRFbIZ5ZBXFg--~B/aD02NzU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/apbC75v0joJeGGZArvqIvw--~B/aD02NzU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/105b2acef7bf0873f24b78932b1fdc3c","width":900,"height":675,"tag":"original"},{"url":"https://s.yimg.com/uu/api/res/1.2/9PhM3ZlBopegGosMLV3W7A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/apbC75v0joJeGGZArvqIvw--~B/aD02NzU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/105b2acef7bf0873f24b78932b1fdc3c","width":140,"height":140,"tag":"140x140"}]},"relatedTickers":["GILD"]},"6cbf7a91-cd50-3536-b272-0ed92f1ba276":{"uuid":"6cbf7a91-cd50-3536-b272-0ed92f1ba276","title":"Texas Lawyer Behind Abortion Ban Takes Aim at HIV Prevention","publisher":"Bloomberg","link":"https://finance.yahoo.com/news/texas-lawyer-behind-abortion-ban-173237154.html","providerPublishTime":1658856757,"type":"STORY","thumbnail":{"resolutions":[{"url":"https://s.yimg.com/uu/api/res/1.2/UYk2lMkYBzej9s1oivkBuA--~B/aD0xNDY5O3c9MjIwMDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/uu/api/res/1.2/8KN01ElJlMYVO11BNVeiyQ--~B/aD0xNDY5O3c9MjIwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/bloomberg_politics_602/5d715c54b55fee73b781464c79d67997","width":2200,"height":1469,"tag":"original"},{"url":"https://s.yimg.com/uu/api/res/1.2/H.6NibFfCitdd9IUmOAKOA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/8KN01ElJlMYVO11BNVeiyQ--~B/aD0xNDY5O3c9MjIwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/bloomberg_politics_602/5d715c54b55fee73b781464c79d67997","width":140,"height":140,"tag":"140x140"}]},"relatedTickers":["GILD"]},"93c563a1-b13f-353c-877a-931849c079ab":{"uuid":"93c563a1-b13f-353c-877a-931849c079ab","title":"Gilead Sciences (GILD) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release","publisher":"Zacks","link":"https://finance.yahoo.com/news/gilead-sciences-gild-expected-beat-140102459.html","providerPublishTime":1658844062,"type":"STORY","thumbnail":{"resolutions":[{"url":"https://s.yimg.com/uu/api/res/1.2/YRz8MGJWcybk9QoXQlMEnQ--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/HIalcDlt7JZPKSITVlxPuw--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/c2fdcaac033e049c74f38d188afcc9f9","width":900,"height":600,"tag":"original"},{"url":"https://s.yimg.com/uu/api/res/1.2/o6VhAe2Lh5wjpYDfWJVJYQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/HIalcDlt7JZPKSITVlxPuw--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/c2fdcaac033e049c74f38d188afcc9f9","width":140,"height":140,"tag":"140x140"}]},"relatedTickers":["GILD","RARE"]},"4aca8bc8-4978-3495-b689-1d9cc116976d":{"uuid":"4aca8bc8-4978-3495-b689-1d9cc116976d","title":"Gilead (GILD) Gets Positive CHMP Opinion for Veklury & Tecartus","publisher":"Zacks","link":"https://finance.yahoo.com/news/gilead-gild-gets-positive-chmp-160304436.html","providerPublishTime":1658764984,"type":"STORY","thumbnail":{"resolutions":[{"url":"https://s.yimg.com/uu/api/res/1.2/rSifIemjGs.ArOt6hbnGLA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/RTGo4pt.TK_E0ckeUDNmXA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/6f5ec5179112ff02b207f8fd4685c071","width":635,"height":400,"tag":"original"},{"url":"https://s.yimg.com/uu/api/res/1.2/IJCPk1k_kHOXYeWqzifXfg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/RTGo4pt.TK_E0ckeUDNmXA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/6f5ec5179112ff02b207f8fd4685c071","width":140,"height":140,"tag":"140x140"}]},"relatedTickers":["BNTX","GILD"]},"ef01f784-a52c-33ad-882c-445ef339bcf5":{"uuid":"ef01f784-a52c-33ad-882c-445ef339bcf5","title":"Kite\u2019s CAR T-cell Therapy Tecartus\xae Receives Positive CHMP Opinion in Relapsed or Refractory Acute Lymphoblastic Leukemia (r/r ALL)","publisher":"Business Wire","link":"https://finance.yahoo.com/news/kite-car-t-cell-therapy-134200146.html","providerPublishTime":1658497320,"type":"STORY","thumbnail":{"resolutions":[{"url":"https://s.yimg.com/uu/api/res/1.2/VNPCvxNNHMERh.u5pdYVvA--~B/aD0yMTA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/DMLEZx462rcxf6fFOJEfow--~B/aD0yMTA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/69634d16f8c8bc7bfbdaee6cfd2cb141","width":480,"height":210,"tag":"original"},{"url":"https://s.yimg.com/uu/api/res/1.2/PN1leJQE5XXBfAXzKUIV.Q--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/DMLEZx462rcxf6fFOJEfow--~B/aD0yMTA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/69634d16f8c8bc7bfbdaee6cfd2cb141","width":140,"height":140,"tag":"140x140"}]},"relatedTickers":["GILD"]},"749711b7-b3e3-33e1-8bda-335b59d1fa77":{"uuid":"749711b7-b3e3-33e1-8bda-335b59d1fa77","title":"Youth Can\'t Wait - Empowering Young People in the Fight Against Hepatitis","publisher":"News Direct","link":"https://finance.yahoo.com/news/youth-cant-wait-empowering-young-124519783.html","providerPublishTime":1658493919,"type":"STORY","relatedTickers":["GILD"]},"6499d300-2c50-3abb-a787-dfcae6a0fa81":{"uuid":"6499d300-2c50-3abb-a787-dfcae6a0fa81","title":"CHMP Adopts Positive Opinion Recommending Veklury\xae (Remdesivir) Receive Full Marketing Authorization for the Treatment of Patients With COVID-19","publisher":"Business Wire","link":"https://finance.yahoo.com/news/chmp-adopts-positive-opinion-recommending-110600654.html","providerPublishTime":1658487960,"type":"STORY","thumbnail":{"resolutions":[{"url":"https://s.yimg.com/uu/api/res/1.2/00ah5Z85rCq83s0rjOk8Xw--~B/aD0xNjA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/BuGXVFuhkaT.B7j3TiIQLg--~B/aD0xNjA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/59af9fb6cf16744cca9b014f53e0f835","width":480,"height":160,"tag":"original"},{"url":"https://s.yimg.com/uu/api/res/1.2/dtyQYk3oTXVLOu_h2fTAAw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/BuGXVFuhkaT.B7j3TiIQLg--~B/aD0xNjA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/59af9fb6cf16744cca9b014f53e0f835","width":140,"height":140,"tag":"140x140"}]},"relatedTickers":["GILD"]},"671377db-e309-3eae-8a6f-f71925a6ae48":{"uuid":"671377db-e309-3eae-8a6f-f71925a6ae48","title":"Scientific Innovation and Collaboration Highlighted at AIDS 2022 as Gilead Extends Leadership Efforts Toward Ending the Global HIV Epidemic","publisher":"Business Wire","link":"https://finance.yahoo.com/news/scientific-innovation-collaboration-highlighted-aids-123000134.html","providerPublishTime":1658406600,"type":"STORY","thumbnail":{"resolutions":[{"url":"https://s.yimg.com/uu/api/res/1.2/wecT5yZj4vDvYdQ9iyXT4w--~B/aD0xNjA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/n2.bIz_4HUNBoaCfX0Feqg--~B/aD0xNjA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/55eaee9e7b7430ef1f5d753ae0af10fc","width":480,"height":160,"tag":"original"},{"url":"https://s.yimg.com/uu/api/res/1.2/A16N1UvFnCnr.kdQnHKgFQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/n2.bIz_4HUNBoaCfX0Feqg--~B/aD0xNjA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/55eaee9e7b7430ef1f5d753ae0af10fc","width":140,"height":140,"tag":"140x140"}]},"relatedTickers":["GILD"]}}')}}]);